PDA

View Full Version : General Cancer News

Pages : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 [15] 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51
  1. Postmenopausal women who consume aromatase inhibitors develops high risk for cardiova
  2. Researchers verify several factors associated with increased risk of brain metastases
  3. Large percentage of women do not get regular mammograms, AACR reports
  4. Results of Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer to b
  5. Worse disease-free survival seen in obese (ER)-positive/HER2-negative breast cancer p
  6. Entinostat plus erlotinib improves survival in NSCLC patients with elevated E-cadheri
  7. Привет
  8. Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast c
  9. Nektar's new NKTR-102 Phase 2 data in metastatic breast cancer to be presented at 33r
  10. HRT with estrogen alone may reduce risk of breast cancer: Study
  11. Weightlifting may help prevent lymphedema following breast cancer treatment
  12. Positive preliminary results from tivozanib-paclitaxel combination Phase 1b trial in
  13. Depression drug appears to be effective in reducing pain with breast cancer treatment
  14. DNA sequence variation may modulate onset of ER positive breast cancer and its recurr
  15. CTCs adds prognostic marker in metastatic breast cancer at first-line chemotherapy
  16. Overexpression of HOXB7 raise tamoxifen resistance for early-stage breast cancer pati
  17. Phase III study shows comparison of lapatinib and trastuzumab with chemotherapy for e
  18. Denosumab delays skeletal-related side effects in breast cancer and bone metastases p
  19. Знакомства
  20. CTCs in metastatic breast cancer patients linked to cancer recurrence followed by ste
  21. Prostate cancer study identifies 295 genes associated with clinical recurrence follow
  22. Novelos NOV-002 demonstrates positive results in Phase 2 neoadjuvant breast cancer tr
  23. Xeloda may reduce recurrence of faster growing breast cancers: Study
  24. Simple fingertip test may help evaluate risk for CTS in breast cancer patients
  25. Scientists to discover true breakthrough in healthful aging
  26. Boehringer Ingelheim reports positive results from afatinib phase IIb/III LUX-Lung 1
  27. Combination therapy improves tumor response in HER2-positive breast cancer patients
  28. Do not delay breast cancer therapy during pregnancy
  29. Presence of circulating tumor cells in early-stage breast cancer doubles risk of rela
  30. Scientist to demonstrate triple-drug cocktail for triple negative breast cancer
  31. Higher co-payments lead to early discontinuation of life-saving therapy for breast ca
  32. Syndax reports promising results from entinostat preclinical studies in breast cancer
  33. Exemestane may provide post-surgery option for postmenopausal women with hormone-rece
  34. SPECT-CT scan utilized for breast cancer radiotherapy
  35. First-ever Prophylactic Cancer Vaccine Conference to be held in Tempe, Arizona
  36. GeparQuinto study data on bevacizumab plus chemotherapy in early breast cancer to be
  37. Strategies for securing life insurance policy for pre-existing medical conditions
  38. bioTheranostics reports new findings from study evaluating Breast Cancer Index molecu
  39. PLATO Foundation launches first medical education activity during 33rd CTRC - AACR Sy
  40. Bionovo reports positive Menerba clinical program meeting with FDA
  41. FOXA1 gene controls oestrogen-fuelled growth of breast cancer cells
  42. UCSF devices could reduce hair loss in breast cancer patients undergoing chemotherapy
  43. Even small amount of alcohol increases chances of developing cancer
  44. Lack of strong molecular 'glue' allows tumour cells to break away and spread
  45. Nektar reports positive results from NKTR-102 Phase 2 study in metastatic breast canc
  46. Genomic Health announces results of Oncotype DX test in early-stage breast cancer pat
  47. Response Genetics presents two gene expression analysis for personalized cancer thara
  48. Unigene enters agreement with GSK to advance oral PTH Phase 2 program for osteoporosi
  49. Provectus commences PH-10 Phase 2c trial for psoriasis
  50. Study reports role of cFLIP in breast cancer cells' resistance to TRAIL-induced apopt
  51. Scientists at Kimmel Cancer Center proves breast inflammation promotes development an
  52. UT Southwestern researchers discover cancer genes forecast survival time and new trea
  53. Tumor suppressor p53 may serve as 'Guardian against Genome Reprogramming'
  54. Domainex wins 2010 Genesis Life Science Innovation and Enterprise Programme Of The Ye
  55. BSGI/MBI provides additional information when conventional imaging is indeterminate i
  56. Enzon in collaboration with NCI initiates EZN-2968 and EZN-2208 Phase I studies for a
  57. PEG-Prom encased nanoparticle aids in cancer detection and treatment
  58. New findings says TRIM24 protein plays active role in breast cancer formation
  59. Study demonstrates BRACAnalysis testing for women with breast carcinoma in situ
  60. DeCODE Genetics identify SNPs to derive PSA threshold for diagnosing prostrate cancer
  61. Some cancers more prevalent in the wealthy
  62. Today's Opinions: Health law spending; Funding threats undercut U.S. legal tradition;
  63. FDA recommends removal of breast cancer indication from Avastin label
  64. Study: Biomarkers may aid in early diagnosis of breast cancer
  65. Genetic biomarker that indicates increased risk for breast cancer found in 'junk' DNA
  66. Genentech confirms EMA, FDA updates on Avastin for metastatic breast cancer
  67. FDA's decision on Avastin will take away choice for many patients, says Breastcancer.
  68. Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzhei
  69. First Edition: December 17, 2010
  70. Today's Opinions: Cucinelli argues for quickly moving Va. case to the Supreme Court;
  71. FDA moves to curb Avastin's approval for breast cancer
  72. DiaGenic issues notification of trade among insiders
  73. Take charge of your medical tests
  74. Researchers find KILLIN is a predisposition gene for Cowden syndrome
  75. Today's Opinions: Congressional funding vote leaves out health law; Price controls on
  76. FDA approves Watson's novel oral contraceptive
  77. P-Rex1 expression may develop metastasis in breast cancer patients
  78. Earlier diagnosis in Cowden syndrome patients predisposed to breast and kidney cancer
  79. Cancer survival rates improving
  80. Breast cancer survival techniques for dealing with challenges on the job and in life
  81. Biomics oversees SGIker DNA Bank to analyse Basque immigrant DNA
  82. Hormone enhanced meat taken off shelves at Coles
  83. FDA approves Endo's FORTESTA Gel for low testosterone
  84. Dosing initiated in combination Phase I study of palifosfamide with etoposide and cis
  85. Cyfluent Chart, Version 2.0 receives Complete EHR certification
  86. First whole genome sequence of Parsi breast cancer woman
  87. Peptide in blood and tissue inhibits growth of breast tumors
  88. CDK1 with phosphate group arrests EZH2 enzyme that may spread cancer
  89. Personalities affect women's outlook after breast loss, reconstruction in cancer pati
  90. Speaker Pelosi releases statement on Republican legislation to repeal the Affordable
  91. Revolutions Medical reworks exclusive license with Traxyz for breast biopsy localizat
  92. Single cancer cell could be detected in future using new test
  93. Alnylam presents ALN-VSP Phase I trial results for liver cancer
  94. OpEds: Sebelius, Fla. Attorney General, USA Today, Wash Post opine about repeal strat
  95. Sanofi-aventis announces NEJM published positive BSI-201 phase II results for breast
  96. New technique to analyze and quantify changes in protein
  97. Study shows clinical benefits of iniparib in combination with standard chemotherapy f
  98. MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer
  99. Elevated fat and cholesterol levels in diet may play a role in breast cancer developm
  100. Intrexon Corporation, ZIOPHARM enter partnership to develop, commercialize DNA-based
  101. Hologic announces acquisition of Interlace Medical
  102. Malaria drug makes cancer drug more effective
  103. Specific silicon microdevices may provide new way to screen breast cancer cells
  104. Quality of life measures most useful for clinical decision-making in trials with QOL
  105. Hello to all members!
  106. VCU Massey Cancer Center introduces safer, more effective form of radiation therapy
  107. LibiGel may be the first FDA approved product to treat HSDD in menopausal women
  108. Silicon microdevices may provide new way to screen metastatic breast cancer cells
  109. Basal-like breast cancer is equally aggressive disease in African American women and
  110. Study identifies over 30 breast cancer gene targets involved in drug resistance to ch
  111. Study to identify early warning biomarkers for presence of breast and prostate cancer
  112. Study supports use of telomerase inhibitors for treatment of childhood cancers
  113. Epigenetic therapy holds promise for cancer management
  114. Targeted delivery of cisplatin prodrug provides safe, effective prostate cancer thera
  115. Doctors matter in treatment of breast cancer
  116. MMRF, Synta collaborate for clinical development of ganetespib in multiple myeloma
  117. Preoperative Breast MRI accurately detects otherwise occult cancer
  118. Genomic research could help doctors better target oxaliplatin drug to treat colorecta
  119. Study: Women with abnormal mammograms experience lower QoL and increased anxiety
  120. Exposure to room light prior to bedtime suppresses melatonin levels, increases cancer
  121. Research study to develop rapid, inexpensive blood screening test for early diagnosis
  122. University of Illinois receives Friends of Mel Foundation support grant for Bone Marr
  123. Scientists identify new way of attacking breast cancer stem cells
  124. New way to halt lung inflammation
  125. PAM50 test is now available to classify breast cancer subtypes
  126. Diabetes increases risk of death in breast cancer patients
  127. Modifiable and non-modifiable lifestyle factors influence breast cancer risk
  128. Postmenopausal women receiving estrogen plus progestin at increased risk of breast ca
  129. Cancer cells brought back under normal control
  130. MD Anderson experts create plan to help guide women of all ages for practicing health
  131. Health care reform should mend disconnect between USPSTF recommendations and Medicare
  132. Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thromboc
  133. ZIOPHARM's darinaparsin receives EMA COMP orphan drug designation for treatment of pe
  134. Researchers discover nitroxoline can reduce human breast and bladder cancer cell grow
  135. Breast cancer patients who have strong social support are less likely to die
  136. Routine mammograms can show arterial calcium deposits in women with ESRD, CKD
  137. Precision highlights role of ChemoFx test, multi-gene predictors for breast cancer
  138. Sunshine and Binghamton University enter research agreement for cancer compound
  139. Medicare reimbursed for only a fraction of the services recommended by government tas
  140. FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic ca
  141. Tamoxifen may reduce individual's risk of death from lung cancer: New study
  142. Contagious cancer repairs own genetic mutations
  143. Fat grafting safety review published; no increased risk of cancer
  144. Blocking rogue gene may stop cancer spread: Study
  145. Breast and lung cancer: Shared risk and treatment
  146. Researchers design engineered organ to study nanoparticle use in breast cancer cell d
  147. New study finds disparities in chlamydia screening
  148. Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Co
  149. P.I.C., Pink Ladies raise funds for Breast Cancer Care
  150. FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine
  151. ASPS, FDA collaborate to establish national breast implant registry
  152. How estrogen decreases risk and delays onset and progression of Alzheimer's disease
  153. Plexxikon begins PLX5622 Phase 1 trial in patients with rheumatoid arthritis
  154. Provectus announces completion of PV-10 Phase 1 trial in patients with liver cancer
  155. Gene signature can accurately predict breast cancer outcomes
  156. Aging-associated protein deficiency may lead to positive breast cancer in women
  157. Iniparib Phase III study in metastatic triple-negative breast cancer does not meet pr
  158. Study finds younger age yearly mammogram screening reduces breast cancer deaths
  159. XYTOS shares cancer patient treatment results
  160. XYTOS launches Cancer Diagnostic Fluorescent Scanning Technique to detect breast, ski
  161. Hormonal therapy during menopause time may increase risk of breast cancer
  162. Genetic study helps investigators solve medical mysteries
  163. Bionovo prices public offering of common stock at $1.30 per share
  164. FDA reports possible association between breast implants, ALCL
  165. Computer glitch gives two women all clear from breast cancer wrongly
  166. New study: FUS protein appears to inhibit growth of prostate cancer cells in lab
  167. New study finds link between race and treatment delay in women with breat cancer
  168. Research on triple negative disease can benefit patients with breat cancer
  169. Johns Hopkins-led safety checklist program appears to reduce hospital deaths by 10%
  170. CINJ Foundation, Panera Bread enter joint venture to fight against cancer
  171. Novel personalized therapy could treat metastatic melanoma and metastatic synovial ce
  172. MRI screening for breast cancer delivers fewer false-positive results over time
  173. American Cancer Society reports racial disparity continues to increase death rate for
  174. John Snow sponsors MEDEA 2011 conference
  175. Quebec provides access to new treatment for women with postmenopausal osteoporosis in
  176. Scientists discover new way breast cancer cells that dodge immune system, promote tum
  177. Trained dog sniffs out colon cancer with 98% accuracy
  178. Microbubble contrast- enhanced ultrasound improves identification of sentinel lymph n
  179. Study: Obese women may avoid mammograms because of pain
  180. Researchers find breast cancer therapy contributes to early-in-life hip fractures in
  181. Elsevier acquires Cancer Information Group's oncology journals portfolio
  182. Elsevier announces publication of two position statements from EMAS in Maturitas jour
  183. USPTO issues notice of allowance to Vermillion's breast cancer biomarkers
  184. Enrollment stopped in one of two global necitumumab Phase III studies in NSCLC
  185. Study reveals how MMSET gene enables disease-causing mutations to occur
  186. New concrete actions on cancer prevention in Europe
  187. Scientists unravel mystery about how new tumors in individuals with breast cancer tak
  188. Women's risk of getting breast cancer increases from one in nine to one in eight
  189. U.S. Patent Office issues Notice of Allowance to Antigen Express AE37 cancer vaccine
  190. New study provides insight into mechanism behind breast cancer mutation
  191. More needs to be done globally to fight cancer
  192. American Cancer Society report released on World Cancer Day
  193. Merck reports GAAP net income of $861 million for 2010
  194. Hologic receives FDA approval for hydroxyprogesterone caproate injection
  195. EntreMed announces publication of ENMD-2076 Phase 1 results against solid tumors in A
  196. Physicians reaction to FDA decision to rescind breast cancer indication from Avastin
  197. Patients receiving cancer treatment may experience skin, hair, nail problems
  198. Studies show growing problems of non-communicable diseases in low-, middle-income cou
  199. Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN
  200. Viewpoints: (Still) Debating health law's constitutionality; Food labels; Lawmakers'
  201. Dots to donate $91,086 for Cure's 'Girlfriends Giving Back' partnership program
  202. More than 6% of bowel cancer patients in Scotland died within 30 days of diagnosis
  203. Study estimates 1.3 million cancer deaths in Europe in 2011
  204. Aushon BioSystems enters diagnostic development collaboration with Peking University
  205. Study finds breast cancer patients do not benefit from axillary lymph node dissection
  206. BD and UCLB enter agreement for development of new diagnostics for ovarian, breast ca
  207. WIN Consortium proposes unique alliance to fight cancer
  208. Indiana University creates Institute for Personalized Medicine
  209. Imaging Diagnostic Systems completes installation of CTLM breast imaging system in Ja
  210. More research needed to determine link between folic acid and breast cancer
  211. Positive safety data from BioSante's ongoing LibiGel Phase III study for HSDD treatme
  212. Selenia Dimensions System receives FDA approval for 3-D X-ray mammography device
  213. FDA approves Hologic's 3-D digital mammography system to diagnose breast cancer
  214. JDR releases research report on Osteonecrosis of the jaw
  215. Oestrogen reduces risk of breast cancer: Study
  216. NHGRI's new strategic plan to identify genetic bases of most single-gene disorders
  217. Neoprobe achieves accrual goal in Lymphoseek Phase 3 study in breast cancer/melanoma
  218. U-Systems completes pivotal study for automated breast ultrasound cancer screening
  219. State Roundup: Calif. adult day care; S.C.'s budget cuts; Minn. 'boomer bust'
  220. Screening breast MRIs can detect invasive cancers in women with history of chest irra
  221. Unmet need for medical help to address sexual issues in breast, gynecologic cancer su
  222. Hunk protein inhibition might provide new approach to treat HER2-positive breast canc
  223. Women with breast cancer can benefit from Breast Angel system
  224. Bisphosphonates appear to reduce risk of postmenopausal colorectal cancer by 50%
  225. Study: Overexpression of EZH2 protein promotes breast cancer progression
  226. Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors
  227. CTI's fourth quarter net loss increases to $34.1 million
  228. Diagnosis of breast cancer in women over 70 leads to lower survival
  229. New review: Multiple interventions might enable work-related outcomes among cancer su
  230. UT Southwestern treats breast-cancer patient with Accuray CyberKnife System
  231. Passion for dancing helps beat breast cancer
  232. Bone remodeling inflammatory protein linked to metastatic lung cancer development in
  233. Astellas, AVEO enter development, commercialization agreement for tivozanib
  234. Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer pati
  235. Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Sympos
  236. Study analyses number of mortality rates among women with breast cancer in Spain
  237. 1000th clinical trial added to Cancer Research UK's patient information website
  238. Viewpoints: Arizona's waiver; next gen's 'different' Medicare?; individual mandate's
  239. DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand
  240. Retired NC judge calls for full compensation on medical malpractice damages
  241. Cyclacel's CYC065 CDK inhibitor demonstrates potential against breast cancer resistan
  242. Researchers discover new 'driver gene' in oestrogen receptor positive breast cancer
  243. 2011 Clinical Congress of American College of Surgeons to take place in October, in S
  244. Biologist investigates CAPV-EAE population for hereditary breast and ovary cancer
  245. Research cuts could mean ongoing cancer deaths
  246. CompanDX, CRL enter multi-year agreement to collaborate in development of biomarker p
  247. Breast cancer cases on the rise in Japan
  248. Gene that causes rare breast cancer identified
  249. New study: Venus White Pro whitens teeth up to 8.4 shades with virtually no sensitivi
  250. GE Healthcare completes Orbotech Medical acquisition